DaVita Cash Flow Statement
DVA / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
DaVita generated $1.9B in operating cash flow and $1.3B in free cash flow in FY2025. Free cash flow margin was 9.6% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $746.8M | $936.3M | $978.5M | $781.6M | $1.2B | $159.4M | $811.0M | $159.4M | $663.6M | $879.9M | $269.7M | $723.1M | $633.4M | $536.0M | $478.0M |
| Depreciation & Amortization | $708.3M | $716.4M | $667.8M | $721.1M | $667.8M | $574.8M | $600.9M | $574.8M | $544.1M | $494.9M | $444.7M | $428.3M | $373.1M | $299.8M | $248.0M |
| Operating Cash Flow | $1.9B | $2.0B | $1.9B | $1.6B | $1.9B | $1.8B | $2.1B | $1.8B | $1.9B | $2.0B | $1.6B | $1.5B | $1.8B | $1.1B | $1.2B |
| Capital Expenditures | $575.9M | $555.4M | $641.5M | $603.4M | $641.5M | $987.1M | $766.5M | $987.1M | $905.3M | $829.1M | $708.0M | $641.3M | $617.6M | $550.1M | $400.2M |
| Free Cash Flow | $1.3B | $1.5B | $1.3B | $961.1M | $1.3B | $784.5M | $1.3B | $784.5M | $1.0B | $1.1B | $849.2M | $818.1M | $1.2B | $550.7M | $779.9M |
| Share Buybacks | $1.3B | $1.4B | $1.5B | $802.2M | $1.5B | $1.2B | $2.4B | $1.2B | $802.9M | $1.1B | $549.9M | - | - | - | $323.3M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | - | - | - | - | - | - | - |
| FCF Margin | 9.6% | 11.4% | 11.1% | 8.3% | 11.1% | 6.9% | 11.5% | 6.9% | 9.3% | 10.7% | - | - | - | - | - |